USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CSX's Q2 earnings showed a 3% revenue decline, pressured by lower fuel surcharges and weak volumes. Find out why I rate CSX ...